Sign in

CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
810710585
Phone
(339) 666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-04 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +32,862 32,862
2025-02-04 Ruddy Marcella K. Chief Medical Officer Grant or award +17,876 49,941
2025-02-04 Ruddy Marcella K. Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +32,502 32,502
2025-02-04 REICIN ALISE Chief Executive Officer Grant or award +36,047 214,344
2025-02-04 REICIN ALISE Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +101,953 101,953
2025-01-28 Schwabish Marc Chief Business Officer Option exercise +2,700 $2.38 $6K 4,700
2025-01-28 Schwabish Marc Chief Business Officer Option exercise · Employee Stock Option (Right to Buy) −2,700 86,514
2024-12-09 Schwabish Marc Chief Business Officer Option exercise +2,000 $2.38 $5K 2,000
2024-12-09 Schwabish Marc Chief Business Officer Option exercise · Employee Stock Option (Right to Buy) −2,000 89,214
2024-12-04 REICIN ALISE Chief Executive Officer Grant or award +11,717 178,297
2024-12-04 REICIN ALISE Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +6,000 6,000
2024-12-03 McNamara Peter Chief Scientific Officer Option exercise +3,500 $2.38 $8K 14,188
2024-12-03 McNamara Peter Chief Scientific Officer Option exercise · Employee Stock Option (Right to Buy) −3,500 34,459
2024-10-22 SPRINGER TIMOTHY A Director Purchase +300,000 $33.59 $10.1M 4,096,764
2024-09-26 SPRINGER TIMOTHY A Director Purchase +24,531 $28.16 $691K 3,771,295
2024-09-26 SPRINGER TIMOTHY A Director Purchase +18,999 $29.13 $553K 3,790,294
2024-09-26 SPRINGER TIMOTHY A Director Purchase +4,070 $30.10 $123K 3,794,364
2024-09-26 SPRINGER TIMOTHY A Director Purchase +2,400 $30.87 $74K 3,796,764
2024-09-24 SPRINGER TIMOTHY A Director Other disposition −1,240,893 310,223
2024-09-24 SPRINGER TIMOTHY A Director Other acquisition +1,054,759 3,746,764

Page 6 of 10 · 188 trades